Cancer immunotherapy targeting Wilms' tumor gene WT1 product. - sprookjes - yvandenbroek - TriplyDB

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

http://www.wikidata.org/entity/Q36238704

about

Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer Immunotherapy for colorectal cancer Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy.The biological basis for immunotherapy in patients with chronic myelogenous leukemia.Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation.WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.T cell-based targeted immunotherapies for patients with multiple myeloma.Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response.Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission.Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination

P2860

Q26749451-9B4C64B0-E172-428C-A771-42E7F06DBA83 Q27021837-DE1C1EA4-AE95-49B5-AF58-FE0CF367DC7D Q30437670-F66C8A12-0A23-4A08-8112-1B615BB61EFF Q35538449-BFD5CF8E-D487-4824-9AB4-C80701FF119C Q36168088-F54F7E98-FA26-44EC-8743-D089D131A301 Q37428671-732D4414-16A4-42C2-AECE-6A2D3E9027C7 Q37560241-E5C9FC50-06AD-4BDC-8344-8D72CB784CD1 Q37731720-C1BD501B-FDFF-43FD-97B6-F6F15E27444B Q38246639-FA781C36-D7F7-4717-90F0-1E112D7D8F4E Q38362636-0EA2038B-B9D3-48D7-8696-B333A2C841E9 Q39537513-4DAC6E09-2988-42C1-B8F0-EC5AC196E291 Q54549001-EE563433-E3DB-4B85-81A5-D5D5842E0883 Q58742957-98B7A7DE-67F1-41D8-AECB-D00FCC0D7391

P2860

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

http://www.wikidata.org/entity/Q36238704

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@ast

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@en

type

label

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@ast

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@en

prefLabel

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@ast

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@en

P1433

Q36238704-EEA29B2D-D233-47C9-A2AD-593732563006

P1476

Q36238704-6579904D-EF4F-4173-9B13-0F368A4ADF0D

P2093

Q36238704-A7487B87-7BC1-4793-9DA1-75BB7C9BC9FB

P2860

Q36238704-00850A4A-F660-412A-9D69-13CDA21C72B7

Q36238704-02C56577-B3D6-45CF-9E8A-3B25D4A06E5E

Q36238704-03A1778F-1648-4E80-9202-119C135154CB

Q36238704-0576B658-A85A-44D6-B28E-5951DD311BC4

Q36238704-0F405E6B-CC56-4241-B8A4-C5C42B1B0ABA

Q36238704-188C8207-C404-4863-B93D-7EF422B4F82C

Q36238704-24435F1C-FED6-42FC-9384-A5CBD7C9C686

Q36238704-3243225C-16CB-4F3C-BA3A-4940C3856820

Q36238704-36991B54-3657-4C5D-A28A-FB937526578C

Q36238704-3AC37B61-DA2A-40C5-82D0-3ACBBBFF3574

P304

Q36238704-1ACD5340-4DBB-4CC9-8AAC-F5C5189FC121

P31

Q36238704-27F3CDA1-909E-4E1B-8FB0-CFDBA1D9F077

P356

Q36238704-28BEE877-B2B1-44D7-925B-06E89999FEDB

P433

Q36238704-90329E3E-EF4D-4E5A-ACA7-4C85C5A0B9A4

P478

Q36238704-529657E3-AD43-42BD-80D9-6CE7694D29E9

P577

Q36238704-A44563CE-CAE3-4199-9CAB-8326801F3998

P698

Q36238704-2B7CFC0B-DBD5-4937-A3F9-4782F06902A4

P921

Q36238704-F4FCD5A9-E9CC-4DE4-B3B2-89393DB6CBA0

P356

14760584.4.4.503

P1433

Expert Review of Vaccines

P1476

Cancer immunotherapy targeting Wilms' tumor gene WT1 product.

@en

P2093

Haruo Sugiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition

Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

Wilms' tumor gene WT1: its oncogenic function and clinical application.

The role of WT1 in oncogenesis: tumor suppressor or oncogene?

WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies.

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

P304

503-512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.4.4.503

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16117707

http://www.w3.org/2001/XMLSchema#string

P921